2
Clinical Trials associated with RGB-5088 / Not yet recruitingPhase 1 评估RGB-5088胰岛细胞注射液治疗1型糖尿病的单中心、单臂、开放性I期临床研究
[Translation] A single-center, single-arm, open-label phase I clinical study evaluating RGB-5088 pancreatic islet cell injection for the treatment of type 1 diabetes
评价RGB-5088胰岛细胞注射液移植治疗1型糖尿病患者的安全性和疗效
[Translation] To evaluate the safety and efficacy of RGB-5088 pancreatic islet cell injection and transplantation in patients with type 1 diabetes
/ Not yet recruitingPhase 1 A Single-Center, Single-Arm, Open-Label Phase I Clinical Trial Evaluating the Safety and Efficacy of RGB-5088 Islet Cell Injection in the Treatment of Type 1 Diabetes Mellitus
This Phase I clinical trial is a single-center, single-arm, open-label study aimed at evaluating the safety and therapeutic efficacy of RGB-5088 islet cell transplantation in patients with Type 1 Diabetes Mellitus.
100 Clinical Results associated with RGB-5088
100 Translational Medicine associated with RGB-5088
100 Patents (Medical) associated with RGB-5088
100 Deals associated with RGB-5088